An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...

Death rates and disability in newborn PAH have declined globally since 1990, but inequalities remain, according to a 30-year ...

The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical worsening among adults with pulmonary arterial hypertension (PAH) who were ...

Sotatercept reduced patient’s risk of deterioration by 76% due to pulmonary hypertension, or high blood pressure in the heart-to-lung system, researchers reported recently in the New England Journal ...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--AliveGen USA Inc. (AliveGen), a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating that its investigational therapy ...

Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease with high morbidity, significant mortality, and poor prognosis. To date, the pathogenesis of PAH is still not clarified, and ...

As coordinator of the REHAR registry, you’ve had a unique perspective on pulmonary hypertension (PH) associated with respiratory diseases in Spain. What have been the most revealing insights from this ...

WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy HYPERION, third Phase 3 study to ...

ABSTRACT: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the selective degeneration of dopaminergic neurons in the substantia nigra pars compacta, resulting in a ...

With a high frequency and a poor prognosis, combined pre-and post-capillary pulmonary hypertension (Cpc-PH) is a significant subtype of pulmonary hypertension linked to left-sided heart disease ...

MHE: What are the latest insights into the underlying pathophysiology of pulmonary arterial hypertension (PAH)? Waxman: Lately, we’ve learned a great deal about the roles of vascular remodeling and ...